跳至主要内容
临床试验/NCT02201862
NCT02201862已完成不适用

Non-Invasive Chromosomal Evaluation of Trisomy Study

Cindy Cisneros3 个研究点 分布在 1 个国家目标入组 2,000 人开始时间: 2014年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
2,000
试验地点
3
主要终点
Detection of aneuploidy

研究概览

简要总结

This study is being conducted to provide clinically annotated samples to support continued improvements in the Ariosa Test content, methodology, specimen processing and quality control.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Subject is at least 18 years old and can provide informed consent;
  • Subject has a viable singleton or twin pregnancy;
  • Subject is confirmed to be at least 10 weeks, 0 days gestation at the time of the study blood draw;
  • Subject is planning to undergo CVS and/or amniocentesis for the purpose of genetic analysis of the fetus OR the subject has already undergone CVS and/or amniocentesis and is known to have a fetus with a chromosomal abnormality confirmed by genetic analysis.

排除标准

  • Subject has known aneuploidy;
  • Subject is pregnant with more than two fetuses or has had sonographic evidence of three or more gestational sacs at any time during pregnancy;
  • Subject has a fetal demise (including natural or elective reduction) identified prior to consent;
  • Subject has history of malignancy treated with chemotherapy and/or major surgery, or bone marrow transplant;

结局指标

主要结局

Detection of aneuploidy

时间窗: 24 months

次要结局

未报告次要终点

研究者

发起方
Cindy Cisneros
申办方类型
Industry
责任方
Sponsor Investigator
主要研究者

Cindy Cisneros

CRA

Roche Sequencing Solutions

研究点 (3)

Loading locations...

相似试验